TransThera Sciences (Nanjing), Inc. (HKG:2617)
Hong Kong · Delayed Price · Currency is HKD
32.15
+0.35 (1.10%)
Jul 17, 2025, 2:41 PM HKT
HKG:2617 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
FY 2024 | FY 2023 | FY 2022 |
---|
Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
---|
| 569.51 | 496.63 | 983.93 |
| 1.4 | 0.55 | 0.42 |
| 3.03 | 341.54 | - |
Cash & Short-Term Investments | 573.93 | 838.72 | 984.35 |
| -31.57% | -14.79% | - |
| 0.46 | 0.6 | 1.05 |
| 0.46 | 0.6 | 1.05 |
| 0.17 | 0.16 | 0.25 |
| 10.69 | 6.12 | 176.67 |
| 585.25 | 845.6 | 1,162 |
Property, Plant & Equipment | 28.77 | 31.62 | 14.5 |
| 0.71 | 0.98 | 1 |
| 14.87 | 8.89 | 11.83 |
|
| 81.24 | 78.58 | 72.24 |
| 12.04 | 13.61 | 14.69 |
Current Portion of Leases | 3.16 | 3.46 | 2.69 |
Current Income Taxes Payable | 0.04 | 0.09 | 0.1 |
| 6.4 | 6.4 | 6.6 |
Other Current Liabilities | 0.48 | 0.43 | 0.75 |
Total Current Liabilities | 103.36 | 102.56 | 97.06 |
| 1.21 | 1.35 | - |
Long-Term Unearned Revenue | - | - | 0.98 |
|
| 381.62 | 381.62 | 379.95 |
Additional Paid-In Capital | 1,573 | 1,573 | 1,555 |
| -1,399 | -1,125 | -781.25 |
Comprehensive Income & Other | -30.59 | -47.05 | -62.02 |
|
Total Liabilities & Equity | 629.6 | 887.09 | 1,190 |
| 4.37 | 4.81 | 2.69 |
| 569.56 | 833.91 | 981.66 |
| -31.70% | -15.05% | - |
| 1.49 | 2.19 | 2.72 |
Filing Date Shares Outstanding | 381.62 | 381.62 | 360.39 |
Total Common Shares Outstanding | 381.62 | 381.62 | 360.39 |
| 481.89 | 743.04 | 1,065 |
| 1.38 | 2.05 | 3.03 |
| 524.32 | 782.2 | 1,091 |
Tangible Book Value Per Share | 1.37 | 2.05 | 3.03 |
| 28.82 | 28.73 | 28.38 |
| 3.52 | 2.9 | - |
| 5.68 | 5.68 | 5.67 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.